FDA warns public against purchase of SM Bonus sugar, other unregistered products
Marje Pelayo • October 28, 2020 • 272
MANILA, Philippines – The Food and Drug Administration (FDA) has issued an advisory warning healthcare professionals and the general public against purchase and consumption of unregistered food products including a common brand of sugar.
FDA Advisory No. 2020-1927 released Wednesday (October 28) named the following products as unregistered:
Melvan Ginger Brew With Turmeric And Lemongrass, 250g
Sweet Valley Freeze Dried Cranberry Coated With Milk Chocolate
Lorenzo Farm Dark Chocolate, 55g
SM BONUS Brown Sugar
SM BONUS Refined Sugar
Based on the agency’s post-marketing surveillance (PMS) activities, the said products were verified to have not been issued with Certificate of Product Registration (CPR).
Thus, the FDA said it cannot guarantee their quality and safety.
It told the public to not purchase the aforementioned violative products.
As per the report, the agency further urged the public to be vigilant against food products that might not be duly registered with FDA.
Also, the agency warned establishments not to advertise, distribute or sell the said violative food products until CPR is issued.
Failure to secure product authorization has its corresponding penalty and sanction, the FDA said.
MANILA, Philippines — The Food and Drug Administration (FDA) strongly advises against the use of ultraviolet (UV) light near or on human body parts for disinfection against coronavirus disease (COVID-19).
The FDA through Republic Act 9711 or the FDA Act of 2009 is mandated to regulate radiation devices such as UV emitting devices.
According to the World Health Organization (WHO), UV radiation can cause skin irritation and damage to eyes due to exposure.
Additionally, the International Commission on Non-Ionizing Radiation (ICNIRP) does not recommend the use of UV lamps for consumers or personal use.
UV radiation is typically classified into three wavebands with varying effects to human health specified as follows:
UV-A (100-280 nm) classified as soft UV with health effects associated with skin aging and other effects;
UV-B (280-315 nm) associated with sunburns, skin cancer and cataracts;
UV-C (100-280 nm) commonly used in ‘germicidal’ or disinfection lamps, also associated with sunburns and eye injury – a condition known as ‘photokeratitis’.
The agency advised the public to follow disinfection protocols from the Department of Health (DOH) like proper handwashing, coughing and sneezing etiquette and physical distancing as best preventive measures against the virus.
MANILA, Philippines — The Food and Drug Administration (FDA) is preparing for the evaluation process of potential vaccines for coronavirus disease (COVID-19) once approved.
Before a vaccine is released for public consumption, it has to go through screening by the FDA, the country’s health product regulatory agency.
The agency assured it can expedite the process so the public can benefit from it at the soonest time possible.
According to FDA Director General Eric Domingo, the evaluation process is usually completed in one month’s time but the FDA is aiming to finish it in two weeks.
“ Bibilis kasi yung evaluation natin for COVID-19 (Our evaluation for COVID-19 will become faster) because unlike with other vaccines before, ngayon meron tayong (this time we have a) vaccine experts panel with DOST who will already be doing like a pre-screening,” Domingo explained.
“Titingnan na nila yung (They will look at) Phase 1 and Phase 2 clinical data then if it fails, it will not proceed to FDA,” he said.
The official further assured that despite the speedy process, the safety of the public will not be compromised.
“We cannot compromise safe for speed. The FDA will expedite the process but no step shall be skipped kasi there are things worse than no vaccine,” he said.
“A bad vaccine is worse than no vaccine and an unsafe or an ineffective vaccine is worse than no vaccine, iyon ang laging sinsabi sa atin ng WHO,” he added.
The FDA is currently dealing with 12 vaccine manufacturers and their vaccines will go through strict evaluation before they receive a certificate of product registration.
“We never said that we will reduce the time for any particular vaccine. All of the vaccines will be checked expeditiously and will be evaluated expeditiously. There will be no special treatment for any of the vaccines,” Domingo said.
Meanwhile, due to still evolving information on COVID-19, experts advise that even after being vaccinated, one should continue to observe minimum health protocols such as proper hand hygiene and wearing of face mask.
“How does it last? We don’t know everything as of now. Our knowledge is evolving so we have no idea yet. Even those who developed actively COVID-19 in previous studies it has been shown that the antibodies wane. Would it be the same with the vaccine? That is something to be seen. We cannot tell yet,” said Dr. Josefina Carlos, a clinical trialist. MNP (with reports from Aiko Miguel)
MANILA, Philippines – The Food and Drug Administration (FDA) is set to launch the clinical trials on six drugs that are candidates for the treatment of coronavirus disease (COVID-19).
According to FDA Director General Eric Domingo, the selected drugs are based on the updates from the Department of Science and Technology (DOST), the agency that has been helping the FDA in searching for a potential vaccine for COVID-19.
The FDA, however, has not disclosed the details on the six candidate vaccines.
In addition to these, Domingo said the Philippines is now preparing to join the Phase 3 Clinical Trials together with other participating countries.
“Posibleng mag-apply at magsasagawa ng Phase 3 Clinical Trials on candidate COVID-19 vaccines sa bansa [We may apply and conduct a Phase 3 Clinical trials on candidate COVID-19 vaccines here in the country],” Domingo said.
“Pinag-uusapan na rin ang pakikilahok ng Pilipinas sa gagawing Solidarity Vaccine Trials ng World Health Organization [There are also discussions on the participation of the Philippines in the upcoming Solidarity Vaccine Trials by the World Health Organization],” he added.
Five of the 166 COVID-19 candidate vaccines that are already in the Phase 3 Clinical Trials include:
Sinopharm- Wuhan Institute of Biological Products
Sinopharm- Beijing Institute of Biological Products
Astrazeneca- University of Oxford
The FDA clarified that though the agency is not involved in the clinical trials, it is the one that regulates the clinical products such as vaccines for public use.
“Kapag napatunayan na ligtas at epektibo ang mga produktong ito, puwede na silang mag-apply for registration sa FDA upang maging available ang mga ito sa merkado,” Domingo explained.
[Once a product is proven safe and effective, the owner may apply for registration to the FDA so it may be available to the market.]
In his state of the nation address, President Rodrigo Duterte mentioned that a vaccine for COVID-19 may soon be out specifically by September this year.
The FDA clarified, however, that developing a vaccine may take months to years, not to mention the strong scientific evidence from clinical trials and the effectiveness and safety of the product for human consumption.
Nonetheless, the FDA is prioritizing the review of a number of applicants for potential vaccine and treatment for COVID-19.
The agency stressed, however, that there is no vaccine or drugs that have been approved yet to be taken by COVID-19 patients.
All drugs that have been selected for trial are still on trial stage and undergoing experts’ evaluation.
“Wala pa pong bakuna kontra COVID-19, kahit saang bansa [There is no vaccine yet for COVID-19 anywhere in the world],” he added.
“Ipakita ninyo po sa amin. Ipadala ninyo po sa amin ang mga detalye at bahala po ang mga ahente namin na manghuhuli dahil mga manloloko po iyan [Show us the product. Send the details to us and our agents will track them and process their arrest because those are fraudulent],” Domingo stressed. –MNP (with reports from Aiko Miguel)
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.